CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Winston Pharmaceuticals Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Winston Pharmaceuticals Inc
100 N Fairway Dr Ste 134
Phone: (847) 362-8200p:847 362-8200 VERNON HILLS, IL  60061-1859  United States Ticker: WPHMWPHM

This company ceased filing statements with the SEC on 6/1/2010.

Business Summary
Winston Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company discovers, develops and commercializes therapeutics for managing and alleviating pain. The Company's late stage candidates include products for the treatment of episodic cluster headache, chronic migraine headache, osteoarthritis, rheumatoid arthritis, neuropathic pain, and pain and inflammation in inflammatory bowel disease. The Company is developing Civamide, which is a transient receptor potential channels vanilloid-1 (TRPV-1) modulator in different dosage forms for several different pain indications. The Company's other products are under development for the treatment of headache and neuropathic and rheumatological pain.
(Source: Company's Website)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-Yes---

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
3/31/201012/31/2009YesYes---

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman of the Board Robert A.Yolles 71 9/22/2009 1/1/2008
President, Chief Executive Officer, Director Joel E.Bernstein 69 9/22/2009 1/1/2008
President, Chief Executive Officer Jeffrey R.Bernstein 41 9/22/2009 9/22/2009
3 additional Officers and Directors records available in full report.

Business Names
Business Name
Winston Laboratories Limited
Winston Laboratories, Inc.
WPHM

General Information
Number of Employees: 9 (As of 3/1/2010)
Outstanding Shares: 77,408,893 (As of 5/10/2010)
Shareholders: 274
Stock Exchange: OTC
Federal Tax Id: 300132755
Fax Number: (847) 362-8394


Copyright © 2021 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, May 1, 2021